J&J will pay $8.9 billion to settle promises cosmetic talc solutions brought about most cancers

J&J will pay .9 billion to settle promises cosmetic talc solutions brought about most cancers


Containers of Johnson’s baby powder made by Johnson and Johnson are exhibited on a shelf on July 13, 2018 in San Francisco, California.

Justin Sullivan | Getty Visuals

Johnson & Johnson on Tuesday reported it will pay $8.9 billion around the next 25 yrs to settle allegations that the company’s toddler powder and other talc items prompted cancer.

The organization proposed the settlement in a securities filing.

But J&J even now pushed back on the talc allegations. 

“The Business carries on to believe that that these statements are specious and absence scientific benefit,” claimed Erik Haas, J&J’s around the globe vice president of litigation, in a statement.

The firm finished gross sales of its talc-based mostly little one powder globally in 2023 just after it confronted 1000’s of lawsuits from buyers proclaiming its talc solutions prompted cancer thanks to contamination with a carcinogen referred to as asbestos.

J&J spun off subsidiary LTL administration in October 2021 in a bid to minimize its losses from litigation and settlement. The firm funneled its talc lawsuits to the subsidiary and declared it bankrupt.

This is breaking news. Be sure to check again for updates.



Resource

Top Wall Street analysts are upbeat about these dividend-paying stocks
World

Top Wall Street analysts are upbeat about these dividend-paying stocks

Optimism about the strong growth opportunities presented by the ongoing artificial intelligence (AI) boom has been tempered by tariff-related distractions and macroeconomic challenges. Against this uncertain backdrop, investors looking for consistent income can add attractive dividend-paying stocks to their portfolios, and studying top Wall Street analysts can offer useful insights into picking the right dividend […]

Read More
JPMorgan’s top short ideas for the second half including Tesla
World

JPMorgan’s top short ideas for the second half including Tesla

Tesla and Moderna are among the stocks JPMorgan advises to sell short heading into the second half of the year. Investors have been largely pushing past the threat of ongoing tariffs placed by the Trump administration on U.S. trading partners. The S & P 500 and tech-heavy Nasdaq Composite each hit a fresh high on […]

Read More
Trump interest in Russia sanctions raises Ukraine allies’ hopes
World

Trump interest in Russia sanctions raises Ukraine allies’ hopes

U.S. President Donald Trump and Ukraine’s President Volodymyr Zelenskyy attend a meeting on the sidelines of NATO summit in The Hague, Netherlands June 25, 2025. Ukrainian Presidential Press Service | Via Reuters A bipartisan U.S. bill that would hit Russia with sanctions in a bid to pressure Moscow into good-faith peace negotiations with Ukraine has […]

Read More